Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from CURRENT PROGRESS IN STRUCTURE-BASED RATIONAL DRUG DESIGN MARKS A NEW MINDSET IN DRUG DISCOVERY. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2001 · External reference
The life history of the first case of myxoedema treated by thyroid extract
10.1136/bmj.1.3089.359 · 1920 · External reference
10.1093/jn/134.6.1299
10.1093/jn/134.6.1299 · External reference
The development of adrenal cortical hormones into drugs
2008 · External reference
The Ring-system of sterols and bile acids. Part II
10.1002/jctb.5000514702 · 1932 · External reference
The biologic properties of cortisone: a review
10.1210/jcem-10-10-1312 · 1950 · External reference
The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years
10.1007/s10822-012-9541-6 · 2012 · External reference
Limiting assumptions in structure-based design: binding entropy
10.1007/s10822-011-9494-1 · 2012 · External reference
Unresolved reference
External reference
10.2533/chimia.2011.863
10.2533/chimia.2011.863 · External reference
Diversity in medicinal chemistry space
10.2174/156802606775193310 · 2006 · External reference
Unresolved reference
External reference
Drug Discovery: As high-throughput screening draws fire, researchers leverage science to put automation into perspective
10.1021/cen-v082n030.p023 · 2004 · External reference
Ligand efficiency: a useful metric for lead selection
10.1016/s1359-6446(04)03069-7 · 2004 · External reference
Unresolved reference
External reference
Hierarchical structure-based virtual screening for drug design
10.1080/13102818.2008.10817525 · 2008 · External reference
Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress
2007 · External reference
10.1016/j.bmc.2006.03.021
10.1016/j.bmc.2006.03.021 · External reference
10.1016/j.drudis.2006.05.012
10.1016/j.drudis.2006.05.012 · External reference
A guide to drug discovery: Hit and lead generation: beyond high-throughput screening
10.1038/nrd1086 · 2003 · External reference
Docking and scoring in virtual screening for drug discovery: methods and applications
10.1038/nrd1549 · 2004 · External reference
10.1007/s10822-011-9519-9
10.1007/s10822-011-9519-9 · External reference
10.1021/jm0495778
10.1021/jm0495778 · External reference
The right road to drug discovery? Fragment-based screening casts doubt on the Lipinski route
2002 · External reference
10.1016/j.bmc.2012.08.050
10.1016/j.bmc.2012.08.050 · External reference
Discovery of AZD3839, a potent and selective BACE1 clinical candidate for the treatment of Alzheimers Disease
2012 · External reference
Structure-guided fragment-based in silico drug design of dengue protease inhibitors
10.1007/s10822-011-9418-0 · 2011 · External reference
Introduction to fragment-based drug discovery
2012 · External reference
The benefits of constructing leads from fragment hits
10.4155/fmc.11.46 · 2011 · External reference
10.1016/j.drudis.2009.04.007
10.1016/j.drudis.2009.04.007 · External reference
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach
10.2174/157340911793743547 · 2011 · External reference
Comparative molecular field analysis and energy interaction studies of thrombin-inhibitor complexes
10.1023/a:1008010016362 · 1999 · External reference
Unresolved reference
2007 · External reference
10.1038/sj.embor.7400236
10.1038/sj.embor.7400236 · External reference
Virtual Screening: A Fast Tool for Drug Design
10.3797/scipharm.0803-03 · 2008 · External reference
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
10.1208/s12248-012-9322-0 · 2012 · External reference
Quo vadis, virtual screening? A comprehensive survey of prospective applications
10.1021/jm101020z · 2010 · External reference
Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening
10.1021/jm100492z · 2010 · External reference
In silico drug discovery approaches on grid computing infrastructures
10.2174/157488410790410560 · 2010 · External reference
Structure-Based Drug Screening and Ligand-Based Drug Screening with Machine Learning
10.2174/138620709788167890 · 2009 · External reference
Structure-based virtual ligand screening: recent success stories
10.2174/138620709789824682 · 2009 · External reference
Essential Factors for Successful Virtual Screening
10.2174/138955708783331540 · 2008 · External reference
Rational design approaches to chemical libraries for hit identification
10.2174/157016306776637564 · 2006 · External reference
Unresolved reference
External reference
New Method for Calculating the Absolute Free Energy of Binding: The Effect of a Mobile Loop on the Avidin/Biotin Complex
10.1021/jp1076752 · 2011 · External reference
10.1021/ja1114198
10.1021/ja1114198 · External reference
Using Free Energy of Binding Calculations To Improve the Accuracy of Virtual Screening Predictions
10.1021/ci200126v · 2011 · External reference
Absolute binding free energy calculations: on the accuracy of computational scoring of protein-ligand interactions
10.1002/prot.22687 · 2010 · External reference
10.1021/ci9002156
10.1021/ci9002156 · External reference
10.1073/pnas.0711686105
10.1073/pnas.0711686105 · External reference
10.1529/biophysj.106.084301
10.1529/biophysj.106.084301 · External reference
Isothermal Titration Calorimetry for Measuring Macromolecule-Ligand Affinity
2011 · External reference
10.1146/annurev.biophys.36.040306.132812
10.1146/annurev.biophys.36.040306.132812 · External reference
Surface plasmon resonance: principles, methods and applications in biomedical sciences
10.1155/2003/372913 · 2003 · External reference
10.1007/s10822-007-9116-0
10.1007/s10822-007-9116-0 · External reference
Unresolved reference
External reference
Is water structure around hydrophobic groups clathrate-like?
10.1073/pnas.92.18.8308 · 1995 · External reference
The energy and entropy of hydration of organic compounds
10.1039/tf9373300229 · 1937 · External reference
The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery
10.2174/1568026033452096 · 2003 · External reference
Entropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design
10.1146/annurev-biophys-083012-130318 · 2013 · External reference
Free Energy Barriers for Escape of Water Molecules from Protein Hydration Layer The journal of Physical Chemistry
10.1021/jp209437j · 2012 · External reference
How to Replace the Residual Solvation Shell of Polar Active Site Residues to Achieve Nanomolar Inhibition of tRNA-Guanine Transglycosylase
10.1002/cmdc.200900343 · 2009 · External reference
10.1021/ja8039663
10.1021/ja8039663 · External reference
10.1039/b612449f
10.1039/b612449f · External reference
Grid inhomogeneous solvation theory: Hydration structure and thermodynamics of the miniature receptor cucurbit[7]uril
2012 · External reference
10.1371/journal.pone.0032036
10.1371/journal.pone.0032036 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1021/jp101461s
10.1021/jp101461s · External reference
10.1021/ja202972m
10.1021/ja202972m · External reference
Solvent effects on protein association and protein folding
10.1002/bip.360290312 · 1990 · External reference
Thermodynamics of buried water clusters at a protein at ligand binding interface
10.1021/jp056020a · 2006 · External reference
10.1021/jp0477912
10.1021/jp0477912 · External reference
10.1002/chem.200901270
10.1002/chem.200901270 · External reference
10.1016/j.jmb.2007.04.008
10.1016/j.jmb.2007.04.008 · External reference
10.1007/s00894-011-0976-9
10.1007/s00894-011-0976-9 · External reference
10.1016/j.sbi.2008.02.004
10.1016/j.sbi.2008.02.004 · External reference
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8
10.1002/prot.22570 · 2009 · External reference
10.1007/s00249-009-0531-0
10.1007/s00249-009-0531-0 · External reference
10.1002/pro.355
10.1002/pro.355 · External reference
10.1371/journal.pone.0000982
10.1371/journal.pone.0000982 · External reference
Unresolved reference
External reference
An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs
10.1007/978-1-60327-317-6_4 · 2009 · External reference
10.1016/j.bcp.2005.12.026
10.1016/j.bcp.2005.12.026 · External reference
10.1016/j.jmb.2005.03.037
10.1016/j.jmb.2005.03.037 · External reference
Unresolved reference
External reference
10.1038/nrd2999
10.1038/nrd2999 · External reference
10.1016/j.drudis.2008.02.007
10.1016/j.drudis.2008.02.007 · External reference
10.1038/nrc2559
10.1038/nrc2559 · External reference
Unresolved reference
External reference
QSCOP—SCOP quantified by structural relationships
2007 · External reference
Structural Evolution of the Protein Kinase–Like Superfamily
2005 · External reference
10.1096/fasebj.9.8.7768349
10.1096/fasebj.9.8.7768349 · External reference
Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA
10.1371/journal.ppat.1002561 · 2012 · External reference
Protein folding: a problem with multiple solutions
2012 · External reference
Comparison of sequence and structure alignments for protein domains
10.1002/prot.10163 · 2002 · External reference
A comparison of Position-Specific Score Matrices based on sequence and structure alignments
10.1110/ps.19902 · 2002 · External reference
Computational Methods for Protein Structure Prediction and Its Application in Drug Design
2011 · External reference
Protein contacts, inter-residue interactions and side-chain Modelling
10.1016/j.biochi.2007.11.007 · 2008 · External reference
IRECS: A new algorithm for the selection of most probable ensembles of side-chain conformations in protein models
10.1110/ps.062658307 · 2007 · External reference
10.1110/ps.04637904
10.1110/ps.04637904 · External reference
10.1016/j.jmb.2005.07.074
10.1016/j.jmb.2005.07.074 · External reference
Docking and quantitative structure–activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors
10.1007/s10822-011-9425-1 · 2011 · External reference
Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide
10.1007/s10822-012-9575-9 · 2012 · External reference
Surflex-Dock: Docking benchmarks and real-world application
10.1007/s10822-011-9533-y · 2012 · External reference
10.1023/a:1020155510718
10.1023/a:1020155510718 · External reference
Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study
10.1007/s10822-006-9092-9 · 2007 · External reference
3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
10.1023/b:jcam.0000004622.13865.4f · 2003 · External reference
10.1007/bf00130399
10.1007/bf00130399 · External reference
A comparative study of fragment screening methods on the p38a kinase: new methods, new insights
10.1007/s10822-011-9454-9 · 2011 · External reference
10.1021/jm049022c
10.1021/jm049022c · External reference
Identifying the binding mode of a molecular scaffold
10.1023/b:jcam.0000022561.76694.5b · 2004 · External reference
10.1038/nrd2199
10.1038/nrd2199 · External reference
Modeling GPCRs
2006 · External reference
10.1016/s0014-5793(04)00320-5
10.1016/s0014-5793(04)00320-5 · External reference
10.1038/nature10361
10.1038/nature10361 · External reference
10.1016/j.tips.2007.06.003
10.1016/j.tips.2007.06.003 · External reference
10.1371/journal.pone.0016811
10.1371/journal.pone.0016811 · External reference
10.1146/annurev-biophys-101209-104901
10.1146/annurev-biophys-101209-104901 · External reference
10.1371/journal.pcbi.1002193
10.1371/journal.pcbi.1002193 · External reference
10.1038/nature08948
10.1038/nature08948 · External reference
10.1038/nature07330
10.1038/nature07330 · External reference
Activation of G Protein-coupled receptors
10.1016/s0065-3233(07)74004-4 · 2007 · External reference
Activation of G protein-coupled receptors entails cysteine modulation of agonist binding
10.1016/s0166-1280(98)90217-2 · 1998 · External reference
10.1016/j.tips.2009.06.003
10.1016/j.tips.2009.06.003 · External reference
10.1016/j.tibs.2009.07.005
10.1016/j.tibs.2009.07.005 · External reference
10.1002/jmr.685
10.1002/jmr.685 · External reference
10.1002/prot.10490
10.1002/prot.10490 · External reference
ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs
10.1186/1471-2105-12-332 · 2011 · External reference
10.1038/nature06325
10.1038/nature06325 · External reference
10.1021/ja077620l
10.1021/ja077620l · External reference
10.1016/j.jmgm.2010.11.005
10.1016/j.jmgm.2010.11.005 · External reference
10.1021/ja105108q
10.1021/ja105108q · External reference
GPCR agonist binding revealed by modeling and crystallography
2012 · External reference
New G-protein-coupled receptor crystal structures: insights and limitations
10.1016/j.tips.2007.11.009 · 2008 · External reference
10.1038/nrd2877
10.1038/nrd2877 · External reference
Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor
2012 · External reference
GPCR-SSFE: A comprehensive database of G-protein-coupled receptor template predictions and homology models
10.1186/1471-2105-12-185 · 2011 · External reference
X-ray structure breakthroughs in the GPCR transmembrane region
10.1016/j.bcp.2009.02.012 · 2009 · External reference
GPCRDB information system for G protein-coupled receptors
10.1093/nar/gkg103 · 2003 · External reference
10.1007/s10822-008-9218-3
10.1007/s10822-008-9218-3 · External reference
10.1016/j.bmcl.2009.05.114
10.1016/j.bmcl.2009.05.114 · External reference
Pharmacophore and receptor models for neurokinin receptors
10.1023/b:jcam.0000017497.58165.d8 · 2003 · External reference
10.1093/protein/gzs037
10.1093/protein/gzs037 · External reference
10.1111/j.1747-0285.2011.01088.x
10.1111/j.1747-0285.2011.01088.x · External reference
Review X-ray structure breakthroughs in the GPCR transmembrane region. Topiol S, Sabio M. Biochem Pharmacol. 2009 Jul 1; 78(1):11–20. Epub 2009 Feb 27. Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures
2011 · External reference
Toward the Discovery of Vaccine Adjuvants: Coupling In Silico Screening and In Vitro Analysis of Antagonist Binding to Human and Mouse CCR4 Receptors
10.1371/journal.pone.0008084 · 2009 · External reference
10.1021/jm800044k
10.1021/jm800044k · External reference
Homology Model-Based Virtual Screening for GPCR Ligands Using Docking and Target-Biased Scoring
10.1021/ci8000265 · 2008 · External reference
10.1021/ci7000814
10.1021/ci7000814 · External reference
10.1007/s10822-007-9127-x
10.1007/s10822-007-9127-x · External reference
10.1007/s10822-006-9067-x
10.1007/s10822-006-9067-x · External reference
10.1002/prot.10237
10.1002/prot.10237 · External reference
10.1023/b:jcam.0000017491.97244.69
10.1023/b:jcam.0000017491.97244.69 · External reference
10.1021/ci200088d
10.1021/ci200088d · External reference
10.1021/jm300280e
10.1021/jm300280e · External reference
Homology Model-Assisted Elucidation of Binding Sites in GPCRs
2012 · External reference
10.3390/ph4091196
10.3390/ph4091196 · External reference
Compounds designed to fit a site of known structure in human haemoglobin
10.1111/j.1476-5381.1976.tb07468.x · 1976 · External reference
Unresolved reference
External reference
Unresolved reference
2006 · External reference
